Policy-oriented research on improved physician incentives for higher value health care.
Abstract
Policy makers (both public and private) are seeking ways to improve the value delivered within our health care system, that is, using fewer resources to provide the same benefit to patients, or using equivalent resources to provide more benefit.
One strategy is to alter the predominant fee-for-service (FFS) economic incentives in the current system. To inform such policy changes, this paper identifies areas in which little is known about the effects of specific incentives (FFS, salary, etc.) on the two components of value: resource use and quality.
Specific suggestions are offered regarding research that would be informative for policy makers, focusing on fundamental "building block" studies rather than overall evaluations of complex interventions, such as accountable care organizations.
This research would better identify critical aspects of the FFS model and salary-based payments that are particularly problematic, as well as situations in which FFS or salary may be less problematic. The research would also explore when alternatives, such as episode-based payment might be feasible, or simply be hypothetical solutions.
The availability of electronic health record-based data in various delivery systems would allow many of these studies to be accomplished in 3-5 years with budgets manageable by public and private funding sources.
Research topics
Related publications
View all publications- Segal JB, Onasanya O, Daubresse M, Lee CY, Moechtar M, Pu X, Dutcher SK, Romanelli RJ.Ther Innov Regul Sci. 2168479018820050. doi: 10.1177/2168479018820050. [Epub ahead of print]2019 Jan 13
- Publication
The economic value of personalized medicine tests: what we know and what we need to know.
Phillips KA, Ann Sakowski J, Trosman J, Douglas MP, Liang SY, Neumann P.Genet Med. 16(3):251-7. doi: 10.1038/gim.2013.122. Epub 2013 Oct 17.2014 Mar 01 - Tai-Seale M, Rice TH, Stearns SC.Health Econ. 1998 May;7(3):199-219.1998 May 01
- Publication
Lower copay and oral administration: predictors of first-fill adherence to new asthma prescriptions.
Berger Z, Kimbrough W, Gillespie C, Boscarino JA, Wood GC, Qian Z, Jones JB, Shah NR.Am Health Drug Benefits. 2(4):174-80.2009 Jun 01 - Wright EA, Steinhubl SR, Jones JB, Barua P, Yan X, Van Loan R, Frederick G, Bhandary D, Cobden D.Am J Manag Care. 2017 Apr 1;23(4):e106-e112.2017 Apr 01




